3rd Mar 2021 16:54
RSA Insurance Group plc
("the Company")
Transactions in shares by Persons Discharging Managerial Responsibility ("PDMRs")
Ordinary Shares of £1.00 each
3 March 2021
The Company announces the following changes to the interests of PDMRs in the Company's Ordinary Shares of £1.00 each ("Shares").
On 2 March 2021 the nil cost Conditional Awards over Shares granted on 2 March 2018 and 2 September 2019 under the terms of the RSA Performance Share Plan 2014 ("PSP") to the following PDMRs vested as shown in the table below. On 2 and 3 March additional shares were sold as shown in the table below.
Name | No. of Performance Shares vested | No. of Dividend Equivalent Shares on Performance Shares | No. of Bonus Deferral Shares Vested | No. of Dividend Equivalent Shares on Bonus Deferral Shares | No. of Restricted Shares Vested | No. of Shares sold to cover statutory deductions |
| Additional sale of Ordinary Shares |
Stephen Hester1 | 188,824 | 15,741 | 79,120 | 6,596 | - | 136,843 |
| - |
Scott Egan1 | 88,959 | 7,416 | 42,867 | 3,573 | - | 67,326 |
| - |
Martin Thompson | 55,412 | 4,619 | 32,702 | 2,726 | - | 51,253 |
| - |
Ralph Daals | 29,229 | 2,436 | 7,087 | 590 | - | 18,547 |
| 20,931 |
Charlotte Heiss | 23,997 | 2,000 | 5,367 | 447 | - | 14,997 |
| 17,637 |
William McDonnell | 31,517 | 2,627 | 15,450 | 1,288 | - | 23,987 |
|
|
Karen Caddick | 19,508 | 509 | - | - | - | 9,437 |
|
|
Charlotte Jones1,2, | 39,713 | 1,038 | - | - | 63,426 | 49,111 |
|
|
Nathan Williams | 40,113 | 3,343 | 18,659 | 1,555 | - | 30,015 |
| 63,638 |
Kenneth Norgrove | 22,420 | 1,868 | 11,495 | 958 | - | 19,163 |
|
|
· Bonus Deferral Shares granted on 2 March 2018 relate to awards made in respect of 2017 as part of the Annual Bonus Plan.
· As the bid for RSA announced on 18 November 2020 fell within the performance period, it has impacted RSA's TSR. Therefore the Remuneration Committee has used its discretion under the PSP rules and approved Directors' Remuneration Policy to delay the final calculation for the TSR condition until there is clarity as to whether the bid will complete.
· The Dividend Equivalent Shares are added to the awards at vesting in accordance with the rules of the PSP and Directors' Remuneration Policy.
· Shares sold to cover statutory deductions were sold at a price of £6.770195 per share on 2 March 2021.
· Shares retained have been transferred to the Computershare nominee account operated by RSA as part of the share plan administration system.
· Additional shares sold, as indicated above, were sold at the prices shown in the individual forms which follow this summary page
Notes to table:
1 A two-year retention period applies to vested Performance Shares, excluding any sold to satisfy statutory deductions, in line with the Directors' Remuneration Policy.
2Awarded to compensate for awards forfeited on leaving previous employer, in accordance with the Directors' Remuneration Policy.
The forms required under the EU Market Abuse Regulation follow.
1. | Details of PDMR / Person Closely Associated ("PCA") | |||||
a) | Name | Stephen Hester | ||||
b) | Position / status | Group Chief Executive | ||||
c) | Initial notification / amendment | Initial Notification | ||||
2. | Details of the issuer | |||||
a) | Name | RSA Insurance Group plc | ||||
b) | LEI | 549300HOGQ7E0TY86138 | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Vesting of Performance Share award granted on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014. The vested shares are subject to a two-year retention period which ends on 2 March 2023. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
188,824 Nil | ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Vesting of Dividend Equivalent Share award granted as part of the Performance Share award on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting. The vested shares are subject to a two-year retention period which ends on 2 March 2023. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
15,741 Nil | ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Vesting of Bonus Deferral Share award granted on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
79,120 Nil | ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Vesting of Dividend Equivalent Share award granted as part of the Bonus Deferral Share award on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
6,596 Nil | ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Sale of shares to cover statutory deductions on share awards vested on 2 March 2021 under the RSA Performance Share Plan 2014. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
136,843 £6.770195 | ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
1. | Details of PDMR / Person Closely Associated ("PCA") | |||||
a) | Name | Scott Egan | ||||
b) | Position / status | CEO, UK and International | ||||
c) | Initial notification / amendment | Initial Notification | ||||
2. | Details of the issuer | |||||
a) | Name | RSA Insurance Group plc | ||||
b) | LEI | 549300HOGQ7E0TY86138 | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Vesting of Performance Share award granted on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014. The vested shares are subject to a two-year retention period which ends on 2 March 2023. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
88,959 Nil | ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Vesting of Dividend Equivalent Share award granted as part of the Performance Share award on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting. The vested shares are subject to a two-year retention period which ends on 2 March 2023. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
7,416
Nil
| ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) |
Nature of the transaction |
Vesting of Bonus Deferral Share award granted on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
42,867 Nil | ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Vesting of Dividend Equivalent Share award granted as part of the Bonus Deferral Share award on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
3,573 Nil | ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Sale of shares to cover statutory deductions on share awards vested on 2 March 2021 under the RSA Performance Share Plan 2014. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
67,326
£6.770195 | ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
1. | Details of PDMR / Person Closely Associated ("PCA") | |||||
a) | Name | Martin Thompson | ||||
b) | Position / status | CEO, Canada | ||||
c) | Initial notification / amendment | Initial Notification | ||||
2. | Details of the issuer | |||||
a) | Name | RSA Insurance Group plc | ||||
b) | LEI | 549300HOGQ7E0TY86138 | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Vesting of Performance Share award granted on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
55,412
NIL
| ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Vesting of Dividend Equivalent Share award granted as part of the Performance Share award on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
4,619 NIL | ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Vesting of Bonus Deferral Share award granted on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
32,702 NIL | ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Vesting of Dividend Equivalent Share award granted as part of the Bonus Deferral Share award on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
2,726 NIL | ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Sale of shares to cover statutory deductions on share awards vested on 2 March 2021 under the RSA Performance Share Plan 2014. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
51,253 £6.770195 | ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
1. | Details of PDMR / Person Closely Associated ("PCA") | |||||
a) | Name | Ralph Daals | ||||
b) | Position / status | Group Chief Auditor | ||||
c) | Initial notification / amendment | Initial Notification | ||||
2. | Details of the issuer | |||||
a) | Name | RSA Insurance Group plc | ||||
b) | LEI | 549300HOGQ7E0TY86138 | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Vesting of Performance Share award granted on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.
| ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
29,229 NIL | ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Vesting of Dividend Equivalent Share award granted as part of the Performance Share award on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
2,436 NIL
| ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Vesting of Bonus Deferral Share award granted on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
7,087 NIL
| ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Vesting of Dividend Equivalent Share award granted as part of the Bonus Deferral Share award on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
590 NIL
| ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Sale of shares to cover statutory deductions on share awards vested on 2 March 2021 under the RSA Performance Share Plan 2014. | ||||
c) |
Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
18,547 £6.770195
| ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
1. | Details of PDMR / Person Closely Associated ("PCA") | |||||
a) | Name | Tatjana Daals | ||||
b) | Position / status | PCA of Ralph Daals, Group Chief Auditor | ||||
c) | Initial notification / amendment | Initial Notification | ||||
2. | Details of the issuer | |||||
a) | Name | RSA Insurance Group plc | ||||
b) | LEI | 549300HOGQ7E0TY86138 | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Sale of shares | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
20,931 £6.77 | ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
1. | Details of PDMR / Person Closely Associated ("PCA") | |||||
a) | Name | Charlotte Heiss | ||||
b) | Position / status | Group General Counsel and Company Secretary | ||||
c) | Initial notification / amendment | Initial Notification | ||||
2. | Details of the issuer | |||||
a) | Name | RSA Insurance Group plc | ||||
b) | LEI | 549300HOGQ7E0TY86138 | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Vesting of Performance Share award granted on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
23,997
NIL
| ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Vesting of Dividend Equivalent Share award granted as part of the Performance Share award on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
2,000
NIL
| ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Vesting of Bonus Deferral Share award granted on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
5,367 NIL | ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23
| ||||
b) | Nature of the transaction | Vesting of Dividend Equivalent Share award granted as part of the Bonus Deferral Share award on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
447 NIL
| ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Sale of shares to cover statutory deductions on share awards vested on 2 March 2021 under the RSA Performance Share Plan 2014. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
14,997
£6.770195
| ||||
e) | Date of the transaction | 2 March 2021
| ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Sale of shares | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
17,637 £6.769585 | ||||
e) | Date of the transaction | 2 March 2021
| ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
1. | Details of PDMR / Person Closely Associated ("PCA") | |||||
a) | Name | William McDonnell | ||||
b) | Position / status | Group Chief Risk Officer | ||||
c) | Initial notification / amendment | Initial Notification | ||||
2. | Details of the issuer | |||||
a) | Name | RSA Insurance Group plc | ||||
b) | LEI | 549300HOGQ7E0TY86138 | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Vesting of Performance Share award granted on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
31,517 NIL
| ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Vesting of Dividend Equivalent Share award granted as part of the Performance Share award on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
2,627
NIL
| ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Vesting of Bonus Deferral Share award granted on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014. | ||||
c) | Price(s) and volume(s) |
| ||||
d) |
Aggregated information - Aggregated volume - Price |
15,450 NIL | ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Vesting of Dividend Equivalent Share award granted as part of the Bonus Deferral Share award on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
1,288
NIL
| ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) |
Place of the transaction |
| ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Sale of shares to cover statutory deductions on share awards vested on 2 March 2021 under the RSA Performance Share Plan 2014. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
23,987
£6.770195 | ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
1. | Details of PDMR / Person Closely Associated ("PCA") | |||||
a) | Name | Karen Caddick | ||||
b) | Position / status | Group & UK HR Director | ||||
c) | Initial notification / amendment | Initial Notification | ||||
2. | Details of the issuer | |||||
a) | Name | RSA Insurance Group plc | ||||
b) | LEI | 549300HOGQ7E0TY86138 | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Vesting of Performance Share award granted on 2 September 2019 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
19,508 NIL | ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Vesting of Dividend Equivalent Share award granted as part of the Performance Share award on 2 September 2019 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
509 NIL | ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Sale of shares to cover statutory deductions on share awards vested on 2 March 2021 under the RSA Performance Share Plan 2014. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
9,437 £6.770195 | ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
1. | Details of PDMR / Person Closely Associated ("PCA") | |||||
a) | Name | Charlotte Jones | ||||
b) | Position / status | Group Chief Financial Officer | ||||
c) | Initial notification / amendment | Initial Notification | ||||
2. | Details of the issuer | |||||
a) | Name | RSA Insurance Group plc | ||||
b) | LEI | 549300HOGQ7E0TY86138 | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Vesting of Performance Share award granted on 2 September 2019 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014. The vested shares are subject to a two-year retention period which ends on 2 March 2023. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
39,713 NIL | ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Vesting of Dividend Equivalent Share award granted as part of the Performance Share award on 2 September 2019 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting. The vested shares are subject to a two-year retention period which ends on 2 March 2023. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
1,038 NIL | ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Vesting of Restricted Share awards granted on 2 September 2019 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014. The vested shares are subject to a six-month retention period which ends on 2 September 2021. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
63,426 NIL | ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Sale of shares to cover statutory deductions on share awards vested on 2 March 2021 under the RSA Performance Share Plan 2014. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
49,111 £6.770195 | ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
1. | Details of PDMR / Person Closely Associated ("PCA") | |||||
a) | Name | Nathan Williams | ||||
b) | Position / status | Group Underwriting Director | ||||
c) | Initial notification / amendment | Initial Notification | ||||
2. | Details of the issuer | |||||
a) | Name | RSA Insurance Group plc | ||||
b) | LEI | 549300HOGQ7E0TY86138 | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Vesting of Performance Share award granted on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
40,113 NIL | ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Vesting of Dividend Equivalent Share award granted as part of the Performance Share award on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
3,343 NIL | ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Vesting of Bonus Deferral Share award granted on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price
|
18,659
NIL | ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Vesting of Dividend Equivalent Share award granted as part of the Bonus Deferral Share award on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
1,555 NIL | ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Sale of shares to cover statutory deductions on share awards vested on 2 March 2021 under the RSA Performance Share Plan 2014. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
30,015 £6.770195 | ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Sale of shares | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
57,611 £6.766258 | ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Sale of shares | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
6,027
£6.776 | ||||
e) | Date of the transaction | 3 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
1. | Details of PDMR / Person Closely Associated ("PCA") | |||||
a) | Name | Kenneth Norgrove | ||||
b) | Position / status | CEO RSA Scandinavia | ||||
c) | Initial notification / amendment | Initial Notification | ||||
2. | Details of the issuer | |||||
a) | Name | RSA Insurance Group plc | ||||
b) | LEI | 549300HOGQ7E0TY86138 | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Vesting of Performance Share award granted on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
22,420 NIL | ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Vesting of Dividend Equivalent Share award granted as part of the Performance Share award on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
1,868
NIL | ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Vesting of Bonus Deferral Share award granted on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
11,495 NIL | ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Vesting of Dividend Equivalent Share award granted as part of the Bonus Deferral Share award on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
958 NIL | ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Sale of shares to cover statutory deductions on share awards vested on2 March 2021 under the RSA Performance Share Plan 2014. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
19,163 £6.770195 | ||||
e) | Date of the transaction | 2 March 2021 | ||||
f) | Place of the transaction | XLON London Stock Exchange | ||||
Enquiries to:
Christopher Smyth, Deputy Group Company Secretary
RSA Insurance Group plc
Tel: +44 (0) 20 7111 7000
Related Shares:
RSA.L